Skip to main content Accessibility help
×
Home
  • Print publication year: 2013
  • Online publication date: September 2013

Chapter 24 - Preventive antibiotics in surgery

from Section 7 - Infectious disease

Summary

Introduction

In 1867, British surgeon Joseph Lister published his landmark series On the Antiseptic Principle of the Practice of Surgery in which he presented his novel technique of applying carbolic acid on surgical wounds to destroy “septic germs” [1]. This “aseptic” technique markedly decreased the incidence of gangrene and death and helped solidify the belief that “minute organisms” were the cause of suppuration. Rapid progress in aseptic technique followed and, coupled with the discovery of antibiotics such as penicillin in the mid-1900s, revolutionized the field of surgery from a practice that had been plagued by frequent infection and death into the discipline it is today. Yet, despite more than a century of great improvements in the prevention of surgical site infections (SSIs) and antimicrobial prophylaxis, surgery-related infections remain a problem.

Over 30 million operative procedures are performed in US hospitals each year, with an overall postsurgical infection rate of 2–5% [2,3]. Among healthcare-associated infections, surgical site infections (SSIs) are the second most common, accounting for 17–20% of all nosocomial infections [2,4]. The US Centers for Disease Control and Prevention (CDC) reports that about 500,000 SSIs occur yearly, but this number is likely an underestimation of the true burden. This underestimation probably can be attributed to the rapid proliferation of outpatient/ambulatory surgeries and shorter postoperative inpatient days, which, in turn, have made the detection of SSIs more difficult. In fact, outpatient operations accounted for 63% of all surgeries performed in US community hospitals in 2002, compared with just 16% in 1980 [5]. In 2006, an estimated 53.3 million surgical and non-surgical procedures were performed in ambulatory surgery centers, yet there is no standardized method for SSI surveillance in these venues [2,6]. Globally, the lack of surveillance systems for SSIs in developing countries makes it difficult to gauge the worldwide burden of SSIs. However, in their meta-analysis of 220 studies of healthcare-associated infections in developing countries, Allegranzi and colleagues estimate that SSIs are the leading cause of nosocomial infections with an incidence up to three times higher than that recorded in developed countries [7].

Related content

Powered by UNSILO
References
Lister, J.On the antiseptic principle in the practice of surgery. Br Med J 1867; 2: 246–8.
Anderson, DJ, Kaye, KS, Classen, D et al. Strategies to prevent surgical site infections in acute care hospitals. Infect Control Hosp Epidemiol 2008; 29 (Suppl 1): S51–61.
Wenzel, RP.Minimizing surgical-site infections. N Engl J Med 2010; 362: 75–7.
Klevens, RM, Edwards, JR, Richards, CL et al. Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep 2007; 122: 160–6.
Agency for Healthcare Research and Quality. Ambulatory Surgery in U.S. Hospitals, 2003 Executive Summary. 2003. .
Cullen, KA, Hall, MJ, Golosinskiy, A.Ambulatory surgery in the United States, 2006. Natl Health Stat Report 2009; 11: 1–25.
Allegranzi, B, Bagheri Nejad, S, Combescure, C et al. Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis. Lancet 2011; 377(9761): 228–41.
Kirkland, KB, Briggs, JP, Trivette, SL et al. The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs. Infect Control Hosp Epidemiol 1999; 20: 725–30.
Whitehouse, JD, Friedman, ND, Kirkland, KB et al. The impact of surgical-site infections following orthopedic surgery at a community hospital and a university hospital: adverse quality of life, excess length of stay, and extra cost. Infect Cont Hosp Epidemiol 2002; 23: 183–9.
Perencevich, EN, Sands, KE, Cosgrove, SE et al. Health and economic impact of surgical site infections diagnosed after hospital discharge. Emerg Infect Dis 2003; 9: 196–203.
Martone, WJ, Nichols, RL.Recognition, prevention, surveillance, and management of surgical site infections: introduction to the problem and symposium overview. Clin Infect Dis 2001; 33 (Suppl 2): S67–8.
Broex, EC, van Asselt, AD, Bruggeman, CA et al. Surgical site infections: how high are the costs?J Hosp Infect 2009; 72: 193–201.
Mangram, AJ, Horan, TC, Pearson, ML et al. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 1999; 20: 250–78.
Haley, RW, Culver, DH, Morgan, WM et al. Identifying patients at high risk of surgical wound infection. A J Epidemiol 1985; 121: 206–15.
Culver, DH, Horan, TC, Gaynes RP and the National Nosocomial Infections Surveillance Systems (NNIS): surgical wound infection rates by wound class, operation and risk index in U.S. Hospitals. Am J Med 1991; 91 (Suppl 3B): 152S–7S.
John, JF, Fishman, NO.Programmatic role of the infectious diseases physician in controlling antimicrobial costs in the hospital. Clin Infect Dis 1997; 24: 471–85.
Sasse, A, Mertens, R, Sion, JP et al. Surgical prophylaxis in Belgian hospitals: estimate of costs and potential savings. J Antimicrob Chemother 1998; 41: 267–72.
Goldstein, EJ.Beyond the target pathogen: ecological effects of the hospital formulary. Curr Opin Infect Dis 2011; 24 (Suppl 1): S21–31.
McDonald, LC.Trends in antimicrobial resistance in health care-associated pathogens and effect on treatment. Clin Infect Dis 2006; 42 (Suppl 2): S65–71.
Spellberg, B, Guidos, R, Gilbert, D et al. The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America. Clin Infect Dis 2008; 46: 155–64.
Engemann, JJ, Carmeli, Y, Cosgrove, SE et al. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis 2003; 36: 592–8.
Cosgrove, SE.The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin Infect Dis 2006; 42 (Suppl 2): S82–9.
Carignan, A, Allard, C, Pépin, J et al. Risk of Clostridium difficile infection after perioperative antibacterial prophylaxis before and during an outbreak of infection due to a hypervirulent strain. Clin Infect Dis 2008; 46: 1838–43.
Crabtree, T, Aitchison, D, Meyers, BF et al. Clostridium difficile in cardiac surgery: risk factors and impact on postoperative outcome. Ann Thorac Surg 2007; 83: 1396–402.
Redelings, MD, Sorvillo, F, Mascola, L.Increase in Clostridium difficile-related mortality rates, United States, 1999–2004. Emerg Infect Dis 2007; 13: 1417–19.
Knight, R, Charbonneau, P, Ratzer, E et al. Prophylactic antibiotics are not indicated in clean general surgery cases. Am J Surg 2001; 182: 682–6.
Hidron, AI, Edwards, JR, Patel, J et al.; National Healthcare Safety Network Team; Participating National Healthcare Safety Network Facilities. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007. Infect Control Hosp Epidemiol 2008; 29: 996–1011.
Passaro, DJ, Waring, L, Armstron, R et al. Postoperative Serratia marcescens wound infections traced to an out-of-hospital source. J Infect Dis 1997; 175: 992–5.
Parry, MF, Grant, B, Yukna, M et al. Candida osteomyelitis and diskitis after spinal surgery: an outbreak that implicates artificial nail use. Clin Infect Dis 2001; 32: 352–7.
Bennett, SN, McNeil, MM, Bland, LA et al. Postoperative infections traced to contamination of an intravenous anesthetic, propofol. N Engl J Med 1995; 333: 147–54.
Ortega, GM, Martí-Bonmatí, E, Guevara, SJ et al. Alteration of vancomycin pharmacokinetics during cardiopulmonary bypass in patients undergoing cardiac surgery. Am J Health Syst Pharm 2003; 60: 260–5.
Finkelstein, R, Rabino, G, Mashiah, T et al. Vancomycin versus cefazolin prophylaxis for cardiac surgery in the setting of a high prevalence of methicillin-resistant staphylococcal infections. J Thorac Cardiovasc Surg 2002; 123: 326–32.
Garey, KW, Lai, D, Dao-Tran, TK et al. Interrupted time series analysis of vancomycin compared to cefuroxime for surgical prophylaxis in patients undergoing cardiac surgery. Antimicrob Agents Chemother 2008; 52: 446–51.
Bolon, MK, Morlote, M, Weber, SG et al. Glycopeptides are no more effective than beta-lactam agents for prevention of surgical site infection after cardiac surgery: a meta-analysis. Clin Infect Dis 2004; 38: 1357–63.
Engelman, R, Shahian, D, Shemin, R et al.; Workforce on Evidence-Based Medicine, Society of Thoracic Surgeons. The Society of Thoracic Surgeons practice guideline series: Antibiotic prophylaxis in cardiac surgery, Part II: Antibiotic choice. Ann Thorac Surg 2007; 83: 1569–76.
Bratzler, DW, Hunt, DR.The surgical infection prevention and surgical care improvement projects: national initiatives to improve outcomes for patients having surgery. Clin Infect Dis 2006; 43: 322–30.
Burke, JF.The effective period of preventive antibiotic action in experimental incisions and dermal lesions. Surgery 1961; 50: 161–8.
Classen, DC, Evans, RS, Pestotnik, SL et al. The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. N Engl J Med 1992; 326: 281–6.
Steinberg, JP, Braun, BI, Hellinger, WC et al.; Trial to Reduce Antimicrobial Prophylaxis Errors (TRAPE) Study Group. Timing of antimicrobial prophylaxis and the risk of surgical site infections: results from the Trial to Reduce Antimicrobial Prophylaxis Errors. Ann Surg 2009; 250: 10–16.
Bratzler, DW, Houck, PM; Surgical Infection Prevention Guidelines Writers Workgroup. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis 2004; 38: 1706–15.
Forse, RA, Karam, B, MacLean, LD et al. Antibiotic prophylaxis for surgery in morbidly obese patients. Surgery 1989; 106: 750–6.
Edmiston, CE, Krepel, C, Kelly, H et al. Perioperative antibiotic prophylaxis in the gastric bypass patient: do we achieve therapeutic levels?Surgery 2004; 136: 738–47.
Dipiro, JT, Cheung, RP, Bowden, TA et al. Single dose systemic antibiotic prophylaxis of surgical wound infections. Am J Surg 1986; 152: 552–9.
Edwards, FH, Engelman, RM, Houck, P et al.; Society of Thoracic Surgeons. The Society of Thoracic Surgeons practice guideline series: Antibiotic prophylaxis in cardiac surgery, Part I: Duration. Ann Thorac Surg 2006; 81: 397–404.
Hall, JC, Christiansen, KJ, Goodman, M et al. Duration of antimicrobial prophylaxis in vascular surgery. Am J Surg 1998; 175: 87–90.
Harbarth, S, Samore, MH, Lichtenberg, D et al. Prolonged antibiotic prophylaxis after cardiovascular surgery and its effect on surgical site infections and antimicrobial resistance. Circulation 2000; 101: 2916–21.
National Institute for Health and Clinical Excellence. Surgical site infection: Prevention and treatment of surgical site infection. 2008. .
Darouiche, RO, Wall, MJ, Itani, KM et al. Chlorhexidine-alcohol versus povidone-iodine for surgical-site antisepsis. N Engl J Med 2010; 362: 18–26.
Saltzman, MD, Nuber, GW, Gryzlo, SM et al. Efficacy of surgical preparation solutions in shoulder surgery. J Bone Joint Surg Am 2009; 91: 1949–53.
Webster, J, Osborne, S.Preoperative bathing or showering with skin antiseptics to prevent surgical site infection. Cochrane Database Syst Rev 2007; 2: CD004985.
van Rijen, MM, Bonten, M, Wenzel, RP et al. Intranasal mupirocin for reduction of Staphylococcus aureus infections in surgical patients with nasal carriage: a systematic review. J Antimicrob Chemother 2008; 61: 254–61.
Perl, TM, Cullen, JJ, Wenzel, RP et al. Mupirocin And The Risk Of Staphylococcus aureus Study Team. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N Engl J Med 2002; 346: 1871–7.
Wilcox, MH, Hall, J, Pike, H et al. Use of perioperative mupirocin to prevent methicillin-resistant Staphylococcus aureus (MRSA) orthopaedic surgical site infections. J Hosp Infect 2003; 54: 196–201.
Kallen, AJ, Wilson, CT, Larson, RJ.Perioperative intranasal mupirocin for the prevention of surgical-site infections: systematic review of the literature and meta-analysis. Infect Control Hosp Epidemiol 2005; 26: 916–22.
Bode, LG, Kluytmans, JA, Wertheim, HF et al. Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N Engl J Med 2010; 362: 9–17.
Yokoe, DS, Mermel, LA, Anderson, DJ et al. A compendium of strategies to prevent healthcare-associated infections in acute care hospitals. Infect Control Hosp Epidemiol 2008; 29 (Suppl 1): S12–21.
Wilson, W, Taubert, KA, Gewitz, M et al.; American Heart Association. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2007; 116: 1736–54. Erratum in: Circulation 2007; 116: e367.
Valentine, RJ, Weigelt, JA, Dryer, D et al. Effect of remote infections on clean wound infection rates. Am J Infect Control 1986; 14: 64–7.
Elek, SD, Conen, PE.The virulence of Staphylococcus pyogenes for man. A study of the problems of wound infection. Br J Exp Pathol 1957; 38: 573–86.
Kalmeijer, MD, Coertjens, H, van Nieuwland-Bollen, PM et al. Surgical site infections in orthopedic surgery: the effect of mupirocin nasal ointment in a double-blind, randomized, placebo-controlled study. Clin Infect Dis 2002; 35: 353–8.
Espenhaug, B, Engesaeter, LB, Vollset, SE et al. Antibiotic prophylactics in total hip arthroplasty. J Bone Joint Surg 1997; 79: 590–5.
Barker, FG. Efficacy of prophylactic antibiotics for craniotomy: a meta-analysis. Neurosurgery 1994; 35(3): 484–90.
Barker, FG. Efficacy of prophylactic antibiotic therapy in spinal surgery: a meta-analysis. Neurosurgery 2002; 51: 391–400.
Korinek, AM, Baugnon, T, Golmard, JL et al. Risk factors for adult nosocomial meningitis after craniotomy: role of antibiotic prophylaxis. Neurosurgery 2006; 59: 126–33.
Barker, FG. Efficacy of prophylactic antibiotics against meningitis after craniotomy: a meta-analysis. Neurosurgery 2007; 60: 887–94.
Ratilal, B, Costa, J, Sampaio, C.Antibiotic prophylaxis for surgical introduction of intracranial ventricular shunts. Cochrane Database Syst Rev 2006; 3: CD005365.
Fekety, FR, Cluff, LE, Sabiston, DC et al. A study of antibiotic prophylaxis in cardiac surgery. J Thorac Cardiovasc Surg 1969; 57: 757–63.
Fong, IW, Baker, CB, McKee, DC.The value of prophylactic antibiotics in aortacoronary bypass operations. J Thorac Cardiovasc Surg 1979; 78: 908–13.
Hasselgren, P, Ivarsson, L, Risberg, B et al. Effects of prophylactic antibiotics in vascular surgery. Ann Surg 1984; 200: 86–92.
Venkatesan, AM, Kundu, S, Sacks, D et al.; Society of Interventional Radiology Standards of Practice Committee. Practice guidelines for adult antibiotic prophylaxis during vascular and interventional radiology procedures. J Vasc Interv Radiol 2010; 21: 1611–30.
Bennion, RS, Hiatt, JR, Williams, RA et al. A randomized, prospective study of perioperative antimicrobial prophylaxis for vascular access surgery. J Cardiovasc Surg 1985; 26: 270–4.
Sonne-Holm, S, Boeckstyns, M, Menck, H et al. Prophylactic antibiotics in amputation of the lower extremity for ischemia. J Bone Joint Surg 1985; 67A: 800–3.
Johnson, JT, Wagner, RL.Infection following uncontaminated head and neck surgery. Arch Otolaryngol Head Neck Surg 1987; 113: 368–9.
Simo, R, French, G.The use of prophylactic antibiotics in head and neck oncological surgery. Curr Opin Otolaryngol Head Neck Surg 2006; 14: 55–61.
Becker, GD, Parell, GJ.Cefazolin prophylaxis in head and neck cancer surgery. Ann Otol Rhinol Laryngol 1979; 88: 183–6.
Coskun, H, Erisen, L, Basut, O.Factors affecting wound infection rates in head and neck surgery. Otolaryngol Head Neck Surg 2000; 123: 328–33.
Tabet, JC, Johnson, JT.Wound infection in head and neck surgery: prophylaxis, etiology, and management. J Otolaryngol 1990; 19: 197–200.
Rubin, J, Johnson, JT, Wagner, RL et al. Bacteriologic analysis of wound infection following major head and neck surgery. Arch Otolaryngol Head Neck Surg 1988; 114: 969–72.
Robbins, KT, Byers, RM, Cole, R et al. Wound prophylaxis with metronidazole in head and neck surgical oncology. Laryngoscope 1998; 98: 803–6.
Piccart, M, Dor, P, Klastersky, J.Antimicrobial prophylaxis of infections in head and neck cancer surgery. Scand J Infect Dis Suppl 1983; 39: 92–6.
Johnson, JT, Yu, V, Myers, EN et al. An assessment of the need for gram-negative coverage in antibiotic prophylaxis for oncological head and neck surgery. J Infect Dis 1987; 155: 331–3.
Simons, JP, Johnson, JT, Yu, VL et al. The role of topical antibiotic prophylaxis in patients undergoing contaminated head and neck surgery with flap reconstruction. Laryngoscope 2001; 111: 329–35.
LoCicero, J, Nichols, RJ.Sepsis after gastroduodenal operations: relationship to gastric acid, motility, and endogenous microflora. South Med J 1980; 73: 878–80.
Lewis, RT, Allan, CM, Goodall, RG et al. Discriminate use of antibiotic prophylaxis in gastroduodenal surgery. Am J Surg 1979; 138: 640–3.
Nichols, RL, Webb, WR, Jones, JW et al. Efficacy of antibiotic prophylaxis in high risk gastroduodenal operations. Am J Surg 1982; 143: 94–8.
Keighley, MRB, Flinn, R, Alexander-Williams, J.Multivariate analysis of clinical and operative findings associated with biliary sepsis. Br J Surg 1976; 63: 528–31.
McGuckin, M, Shea, JA, Schwartz, JS.Infection and antimicrobial use in laparoscopic cholecystectomy. Infect Control Hosp Epidemiol 1999; 20: 624–6.
Sanabria, A, Dominguez, LC, Valdivieso, E et al. Antibiotic prophylaxis for patients undergoing elective laparoscopic cholecystectomy. Cochrane Database Syst Rev 2010; 12: CD005265.
Fry, DE.Preventive systemic antibiotics in colorectal surgery. Surg Infect (Larchmt) 2008; 9: 547–52.
Fry, DE.Surgical site infections and the surgical care improvement project (SCIP): evolution of national quality measures. Surg Infect (Larchmt) 2008; 9: 579–84.
Guenaga, KK, Matos, D, Wille-Jørgensen, P.Mechanical bowel preparation for elective colorectal surgery. Cochrane Database Syst Rev 2009; 1: CD001544.
Clarke, JS, Condon, RE, Barlett, JG et al. Preoperative oral antibiotics reduce septic complications of colon operations: results of prospective, randomized, double-blind clinical study. Ann Surg 1977; 186: 251–9.
Song, F, Glenny, AM.Antimicrobial prophylaxis in colorectal surgery: a systematic review of randomized controlled trials. Health Technol Assessm 1998; 2: 1–110.
Lewis, RT.Oral versus systemic antibiotic prophylaxis in elective colon surgery: a randomized study and meta-analysis send a message from the 1990s. Can J Surg 2002; 45: 173–80.
Itani, KM, Wilson, SE, Awad, SS et al. Ertapenem versus cefotetan prophylaxis in elective colorectal surgery. N Engl J Med 2006; 355: 2640–51.
American Urological Association. Best Practice Statement on Urologic Surgery Antimicrobial Prophylaxis. 2008. .
European Association of Urology. Guidelines on Urological Infections. 2010. .
Berry, A, Barratt, A.Prophylactic antibiotic use in transurethral prostatic resection: a meta-analysis. J Urol 2002; 167: 571–7.
ACOG Committee on Practice Bulletins-Gynecology. ACOG Practice Bulletin No. 104. Antibiotic prophylaxis for gynecologic procedures. Obstet Gynecol 2009; 113: 1180–9.
Litta, P, Sacco, G, Tsiroglou, D et al. Is antibiotic prophylaxis necessary in elective laparoscopic surgery for benign gynecologic conditions?Gynecol Obstet Invest 2010; 69: 136–9.
Smaill, FM, Gyte, GM.Antibiotic prophylaxis versus no prophylaxis for preventing infection after cesarean section. Cochrane Database Syst Rev 2010; 1: CD007482.
American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 47. Prophylactic antibiotics in labor and delivery. Obstet Gynecol 2003; 102: 875–82.
van Schalkwyk, J, Van Eyk, N; Society of Obstetricians and Gynaecologists of Canada Infectious Diseases Committee. Antibiotic prophylaxis in obstetric procedures. J Obstet Gynaecol Can 2010; 32: 878–92.
Sullivan, SA, Smith, T, Chang, E et al. Administration of cefazolin prior to skin incision is superior to cefazolin at cord clamping in preventing postcesarean infectious morbidity: a randomized, controlled trial. Am J Obstet Gynecol 2007; 196: 455.e1–5.
Fabian, TC.Infection in penetrating abdominal trauma: risk factors and preventive antibiotics. Am Surg 2002; 68: 29–35.
Kirton, OC, O'Neill, PA, Kestner, M et al. Perioperative antibiotic use in high-risk penetrating hollow viscus injury: a prospective randomized, double-blind, placebo-control trial of 24 hours versus 5 days. J Trauma 2000; 49: 822–32.